Clinical Trials Logo

Dysphonia clinical trials

View clinical trials related to Dysphonia.

Filter by:

NCT ID: NCT03692494 Not yet recruiting - Dysphonia Clinical Trials

The Effects of Adding Expiratory Muscle Strength Training in Voice Therapy

Start date: September 1, 2024
Phase: N/A
Study type: Interventional

Evaluate if adding expiratory muscle strength training to traditional voice therapy for individuals with dysphonia due to glottal insufficiency improves maximal expiratory pressure, acoustic and aerodynamic measures (i.e. amplitude, maximum phonation time, peak expiratory flow), and voice related quality of life.

NCT ID: NCT03576365 Recruiting - Dysphonia Clinical Trials

Dysphonia, Distress, and Perceived Control: Technology Based Assessment and Intervention

Start date: April 11, 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to pilot test a version of the intervention that has been tailored for participants with dysphonia. The study seeks to determine if the adapted intervention: a) increases perceived control over voice-related stressors and b) decreases stress and distress resulting from voice problems. The study will also explore the usability and acceptability of the program. The goal is to help people with voice problems achieve better voice and quality of life outcomes.

NCT ID: NCT03543150 Recruiting - Dysphonia Clinical Trials

BOTOX® Drug Use Investigation (Spasmodic Dysphonia)

Start date: July 20, 2018
Phase:
Study type: Observational

This study is a drug use investigation program of BOTOX. The objective of this investigation is to collect and assess information on the safety and efficacy of BOTOX injections in subjects with a diagnosis of spasmodic dysphonia in daily clinical practice. All subjects treated with BOTOX for spasmodic dysphonia after obtaining approval for the indication of BOTOX for spasmodic dysphonia will be included in this study. Approximately 400 subjects will be included in the study. The observation period per subject will be up to 12 months from the date of the first administration of BOTOX. The total study duration will be will be approximately 3 years from the date of approval for the indication of BOTOX for spasmodic dysphonia. BOTOX is a registered trademark of Allergan, Inc.

NCT ID: NCT03416868 Completed - Clinical trials for Muscle Tension Dysphonia

Preliminary Study 2 to Test the Effects of Ambulatory Voice Biofeedback

Start date: June 1, 2018
Phase: N/A
Study type: Interventional

Patients with vocal hyperfunction will undergo standard of care voice therapy with ambulatory voice monitoring before therapy and after the first 3 voice therapy sessions. Biofeedback will be added to ambulatory monitoring after the 2nd voice therapy session only.

NCT ID: NCT03380676 Completed - Dysphagia Clinical Trials

Study of Speech Disorders , Voice and Swallowing in Primary Dystonia Oromandibular

DOM
Start date: February 2014
Phase: N/A
Study type: Observational

To better define the clinical characteristics of oromandibular dystonia, we aimed to study voice, speech and swallowing disorders in idiopathic oromandibular We planned to include consecutive patients followed in Lille Movement disorders department for idiopathic oromandibular dystonia and matched, healthy control subjects. Voice and speech disorders had to be assessed with the phonetic analysis, perceptive analysis and motor examination modules of the "Batterie d'Evaluation Clinique de la Dysarthrie" (Clinical Evaluation of Dysarthria), the Grade, Rough, Breathy, Asthenic, Strained scale, and a computer recording. Activities of daily living had to be assessed with the Oromandibular Dystonia Questionnaire, the Voice Handicap Index and the Deglutition Handicap Index.

NCT ID: NCT03368911 Completed - Sore Throat Clinical Trials

The Effect of Reinforced Endotracheal Tube on Post-operative Hoarseness Undergoing Thyroidectomy

Start date: December 1, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is an evaluation of the effect of the reinforced endotracheal tube on post-operative hoarseness and sore throat undergoing thyroidectomy

NCT ID: NCT03368599 Completed - Clinical trials for Postoperative Complications

Endobronchial Intubation of Double-lumen Tube: Conventional Method vs Fiberoptic Bronchoscope Guide Method

Start date: January 15, 2018
Phase: N/A
Study type: Interventional

Double lumen tube (DLT) needs to be intubated to isolate ventilations of left and right lungs for thoracic surgery. Post-operative sore throat and hoarseness are more frequent with DLT intubation than with single one. Which is may because DLT is relatively thicker, harder, sideway curved and therefore more likely to damage the vocal cord or trachea during intubation, and advanced deeper to the carina and main bronchus level. In the conventional method of intubation, DLT is rotated 90 degrees and advanced blindly to the main bronchus level after DLT is intubated through vocal cord using the direct laryngoscopy. After the blind advancement, the sufficient tube position needs to be gained and confirmed with the fiberoptic bronchoscope. In the bronchoscope guide method, after DLT is intubated through vocal cord using the direct laryngoscopy, the pathway into the targeted main bronchus is secured using the fiberoptic bronchoscope which is passed through a bronchial lumen of DLT. And then DLT can be advanced through the guide of the bronchoscope. In this study, we intend to compare post-operative sore throat, hoarseness and airway injury between the two methods. We hypothesize that the bronchoscope guide method can reduce the post-operative complications and airway injury because surrounding tissues of the airway can be less irritated by DLT intubation in the guide method than in a conventional. For a constant guide effect, we use fiberoptic bronchoscopes with same outer diameter (4.1 mm) which can pass through a bronchial lumen of 37 and 39 Fr Lt. DLT and cannot pass through 35 Fr or smaller Lt. DLTs. <Lt. DLT size selection> - male: ≥160 cm, 39 French; < 160 cm, 37 French - female: ≥160 cm, 37 French; < 160 cm, contraindication

NCT ID: NCT03349086 Completed - Clinical trials for Adductor Spasmodic Dysphonia

Effects of Vocal Exercises for Spasmodic Dysphonia

Start date: July 28, 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the effect of voice exercise and voice rest on subject's perception of vocal handicap and communicative participation following Botox injections for adductor spasmodic dysphonia.

NCT ID: NCT03292458 Active, not recruiting - Spasmodic Dysphonia Clinical Trials

Sodium Oxybate in Spasmodic Dysphonia and Voice Tremor

Start date: January 22, 2018
Phase: Phase 2/Phase 3
Study type: Interventional

Using a comprehensive approach of clinico-behavioral testing, neuroimaging and pharmacogenetics, the researchers will examine the clinical effects of sodium oxybate and the matched placebo on voice symptoms in spasmodic dysphonia and voice tremor.

NCT ID: NCT03261141 Not yet recruiting - Dysphonia Clinical Trials

Correlation Between (PV-RQOL), The Auditory Perceptual Assessment and Acoustic Analysis of Voice in Dysphonic Children

Start date: November 1, 2017
Phase: N/A
Study type: Observational

The aim of this study is to assess the Correlation between The Arabic Pediatric Voice Related Quality of Life (PV-RQOL), The Auditory Perceptual Assessment and Acoustic Analysis of voice of dysphonic children. This is important to provide an efficient therapeutic strategy for these children.